Pfaffikon, Zurich, Switzerland The company was established in Europe in Switzerland. The leading representative office of defined VC is situated in the Pfaffikon.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Aeris Capital, startups are often financed by Mohr Davidow Ventures, Kleiner Perkins, Aberdare Ventures. The meaningful sponsors for the fund in investment in the same round are Mohr Davidow Ventures, BioMedPartners, Life Sciences Partners. In the next rounds fund is usually obtained by Venrock, EDBI, Aster.
We also calculated 4 valuable employees in our database.
The average startup value when the investment from Aeris Capital is 50-100 millions dollars. The important activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. This Aeris Capital works on 2 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2014. The fund is constantly included in 2-6 deals per year.
Among the most popular portfolio startups of the fund, we may highlight Butterfly Network, Mode Media, GenomeDx Biosciences. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Health Diagnostics.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alteon Websystems | California, San Jose, United States |
| Czar Capital | England, London, United Kingdom |
| GrowthWorks Atlantic Venture Fund | Canada, Halifax, Nova Scotia |
| GSTC Health Innovations | - |
| Guangzhou Dangui Touzi Youxian Gongsi | China, Guangdong, Guangzhou |
| Hambrecht & Quist | California, San Francisco, United States |
| JAPAN Creative Platform Group | Japan, Tokyo |
| Krantz Holdings | Beverly Hills, California, United States |
| Lantern Capital | Central, Central Region, Singapore |
| mktg | New York, New York, United States |
| Operating Venture Capital | Louisiana, New Orleans, United States |
| Point West Ventures | Alpine, United States, Utah |
| PULLUP | Japan, Tokyo |
| Renhuai Jiu Tou | China, Guizhou, Zunyi |
| Splice Capital | Andhra Pradesh, Hyderabad, India |
| Stream Hill Angels | Beijing, Beijing, China |
| Sungy Mobile | China, Guangdong, Guangzhou |
| Tango | Netherlands, Utrecht, Utrecht |
| Yucaipa Corporate Initiatives Fund | California, Los Angeles, United States |
| Yunxuetang | China, Jiangsu, Suzhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Jiff | $17M | 07 Jun 2016 | Mountain View, California, United States | ||
Solstice Biologics | $4M | 30 Dec 2015 | San Francisco, California, United States | ||
Jiff | $23M | 21 May 2015 | Mountain View, California, United States | ||
Curetis | $17M | 20 Nov 2014 | Germany, Baden-Württemberg, Germany | ||
Jiff | $18M | 23 Sep 2014 | Mountain View, California, United States | ||
Sonetik | 24 Jan 2014 | Zurich, Zurich, Switzerland | |||
Invincea | $16M | 16 Dec 2013 | Virginia, United States | ||
GenomeDx Biosciences | 30 Sep 2013 | Vancouver, British Columbia, Canada | |||
Solstice Biologics | $18M | 04 Jan 2013 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Jiff | $17M | 07 Jun 2016 | Mountain View, California, United States | ||
Solstice Biologics | $4M | 30 Dec 2015 | San Francisco, California, United States | ||
Jiff | $23M | 21 May 2015 | Mountain View, California, United States | ||
Curetis | $17M | 20 Nov 2014 | Germany, Baden-Württemberg, Germany | ||
Jiff | $18M | 23 Sep 2014 | Mountain View, California, United States | ||
Sonetik | 24 Jan 2014 | Zurich, Zurich, Switzerland | |||
Invincea | $16M | 16 Dec 2013 | Virginia, United States | ||
GenomeDx Biosciences | 30 Sep 2013 | Vancouver, British Columbia, Canada | |||
Solstice Biologics | $18M | 04 Jan 2013 | San Francisco, California, United States |
